June is Bowel Cancer Awareness Month
Colorectal cancer, also known as bowel cancer, colon cancer or rectal cancer, affects men and women, young and old. Australia has one of the highest rates of colorectal cancer in
Carina Biotech brings in immunology and oncology experts to accelerate move into the clinic
Carina Biotech has welcomed to its team two new staff members – Professor Shaun McColl and Dr José Iglesias MD. These two experts in immunology, T cell biology, oncology and
The three women leading Carina Biotech
Dr Deborah Rathjen After completing its first (and second) commercial deals in the middle of last year, Carina is now rapidly transitioning from CAR-T discovery company to an emerging clinical
Carina Biotech’s “very promising” data on a potential CAR-T cell therapeutic for colorectal cancer
Carina Biotech scientist Dr Veronika Bandara presented data at this week's Eradicate Cancer Conference on Carina's latest CAR-T cab off the rank that has demonstrated significant killing of two colorectal
Carina Biotech signs agreement with Bionomics Ltd to create cancer-busting CAR-T cells targeted at a cancer stem cell marker abundant in solid tumours
In this worldwide exclusive agreement, Carina Biotech will create Chimeric Antigen Receptor T cells (CAR-T cells) and other adoptive cell therapies to the leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)
Carina Biotech and UniSA develop new device to improve cancer immunotherapies
Carina Biotech and UniSA today announced they have developed a new device to improve cancer immunotherapies. Our researchers at the University of South Australia have developed a novel approach based
Carina Biotech’s second commercial deal – with Sydney-based Glytherix
Carina Biotech and Sydney-based immuno-oncology company Glytherix are pleased to announce a co-development agreement that could result in a promising new CAR-T therapy that is effective in killing a range
Carina Biotech completes its first commercial agreement
Carina Biotech and biopharmaceutical company Biosceptre are pleased to announce they have signed an agreement that will see the advancement of a promising cancer immunotherapy. Biosceptre, developing targeted therapeutics and immune-oncology products,
Carina Biotech welcomes new CEO, Dr Deborah Rathjen
Carina Biotech's board and management team are delighted to welcome Dr Deborah Rathjen as our new CEO. Deborah’s appointment coincides with Carina completing the first commercial transaction of its CAR-T
Carina Biotech wins $750,000 RCSF grant from State Government
Carina Biotech was one of six Adelaide start-ups to share in more than $2.75 million through the State Government's Research Commercialisation and Startup Fund (RCSF). Minister for Innovation and Skills,